Clinical Trials Directory

Trials / Completed

CompletedNCT05182255

Post Market Clinical Study - Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

Status
Completed
Phase
Study type
Observational
Enrollment
127 (actual)
Sponsor
Cook Research Incorporated · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this post-market clinical follow-up study is to evaluate the continued safety and performance of the marketed Evolution® Esophageal Stent System (Partially- and Fully Covered).

Detailed description

Cook Evolution® Esophageal Stent Post-Market Data Collection Study A retrospective observational, multi-center, chart review study will be performed. Data specific to Cook Evolution® Esophageal Stent placement procedures from all consecutive patients who underwent stent placement with any of the stents at the participating sites between 1st January 2015 and 31st December 2020 (index period) will be collected. Research on the commercially available Cook Evolution® Esophageal Stents is being conducted to comply with the new medical device regulation, EU 2017/745, to assess the device for its continued safety and performance. To do this, Cook Research Incorporated is working with participating hospitals to collect pseudonymized (coded) personal health data. This study is in the interest of public health; to learn more about the necessary data processing, please visit the webpage below. https://www.cookresearchinc.com/extranet/pdf/2054-55\_Data\_Protection\_Notice.pdf Spanish: https://www.cookresearchinc.com/extranet/pdf/2054-55\_Data\_Protection\_Notice\_ESP.pdf

Conditions

Interventions

TypeNameDescription
DEVICEEvolution® Esophageal Stent Systems, Europe: Fully and Partially CoveredTo aid in maintaining patency of the esophagus in cases of obstruction of the esophagus caused by an esophageal disease and to seal tracheoesophageal fistula.

Timeline

Start date
2022-04-28
Primary completion
2023-12-08
Completion
2023-12-08
First posted
2022-01-10
Last updated
2025-02-12

Locations

5 sites across 3 countries: Germany, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT05182255. Inclusion in this directory is not an endorsement.